BNP Paribas Financial Markets’s Boundless Bio BOLD Stock Holding History
Bought
Maintained
Sold
Other funds holding BOLD
SAM
SCM
VCM
RC
BNP Paribas Financial Markets's BOLD Position: Q1 2026 in Review
BNP Paribas Financial Markets increased its Boundless Bio (BOLD) stake by 1.1% in Q1 2026, buying an estimated $2 and bringing the position to 178 shares worth $196. The position accounts for ﹤0.01% of the portfolio, ranked #5630.
BNP Paribas Financial Markets first reported a position in BOLD in Q2 2024 and has held it in 8 quarters since. The position peaked at $67.7K in Q3 2024. 36 funds tracked by Wall St. Rank hold BOLD as of Q1 2026.
- BNP Paribas Financial Markets held 178 shares of Boundless Bio worth $196 as of Q1 2026.
- BNP Paribas Financial Markets bought 2 Boundless Bio shares in Q1 2026, an estimated $2.
- Boundless Bio made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q1 2026, its #5630 holding.
- BNP Paribas Financial Markets first reported a position in Boundless Bio in Q2 2024 and has held it in 8 quarters since.
- BNP Paribas Financial Markets's Boundless Bio position peaked at $67.7K in Q3 2024.
- 36 funds tracked by Wall St. Rank held Boundless Bio as of Q1 2026.
Based on BNP Paribas Financial Markets's 13F filing for Q1 2026, filed 12 May 2026.